“Clinical trials today are more responsive, individualized and effective because it’s written into the DNA of CROs to challenge the status quo,’’ according to a new Association of Clinical Research Organizations (ACRO) report, Clinical Research: A Legacy of Innovation, A Future of Transformed Medicine.

The reports says CROs are harnessing real-time data analytics and visual reporting software tools, building innovative strategic partnerships and breaking down communication barriers among sponsors, sites, patients and even regulators.

Douglas Peddicord, Ph.D., ACRO executive director, said, “ACRO members compete on the basis of innovation. While long recognized for their expertise in managing clinical trials, ACRO members today are using their knowledge and expertise to add value throughout the entire discovery, development and delivery cycle—from early clinical studies through commercialization and monitoring of new medical products. Sponsors are benefiting from these innovations as are patients, who benefit from having access to new, more individualized treatments much sooner.”